BofA/Merrill Lynch Downgrades Adaptimmune Therapeutics plc (ADAP) to Underperform
Go back to BofA/Merrill Lynch Downgrades Adaptimmune Therapeutics plc (ADAP) to Underperform(NASDAQ: ADAP) | Delayed: 1.58 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $1.58 | 52 Week High | $12.85 | |||
Open | $1.58 | 52 Week Low | $3.76 | |||
Day High | $1.58 | P/E | N/A | |||
Day Low | $1.58 | EPS | $0.00 | |||
Volume | 50 |